Allarity Therapeutics, Inc. Proceeds from Issuance of Debt
Allarity Therapeutics, Inc. (ALLR) reported Proceeds from Issuance of Debt of $6.82 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2024-03-08
- Allarity Therapeutics, Inc. proceeds from issuance of debt for the quarter ending 2023-12-31 was -$10.08M.
- Allarity Therapeutics, Inc. proceeds from issuance of debt for the quarter ending 2023-09-30 was $10.08M.
- Allarity Therapeutics, Inc. proceeds from issuance of debt for fiscal 2023 was $6.82M.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$10.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $0.00 derived: sum of 2 quarters · filed 2024-03-08 | $6.82M 10-K · filed 2024-03-08 | |
| 2023-09-30 | $10.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $16.89M 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $6.82M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |